ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹98 Cr | ₹138 Cr | ₹132 Cr | ₹123 Cr | ₹86 Cr |
What is the latest Contingent Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹98 Cr |
| Mar2024 | ₹138 Cr |
| Mar2023 | ₹132 Cr |
| Mar2022 | ₹123 Cr |
| Mar2021 | ₹86 Cr |
How is Contingent Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹98 Cr | -28.50 | |
| Mar2024 | ₹138 Cr | 4.57 | |
| Mar2023 | ₹132 Cr | 7.23 | |
| Mar2022 | ₹123 Cr | 43.29 | |
| Mar2021 | ₹86 Cr | - | |
Compare Contingent Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹22,126.5 Cr | -0.6% | 5.6% | 26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -0.6% |
5.6% |
26.4% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses